Literature DB >> 5812007

Response of a "resistant" plasmacytoma to alkylating agents and x-ray in combination with the "excision" repair inhibitors caffeine and chloroquine.

D Gaudin, K L Yielding.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5812007     DOI: 10.3181/00379727-131-34119

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


× No keyword cloud information.
  7 in total

Review 1.  [The role of enzymatic DNA repair in carcinogenesis and cancer chemotherapy].

Authors:  E Harbers
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1978-08-24

2.  The action of ionizing radiation on DNA in the presence of quinacrine. I. UV absorption and fluorescence measurements.

Authors:  A Hissung; H Dertinger; G Heinrich
Journal:  Radiat Environ Biophys       Date:  1975-06-13       Impact factor: 1.925

3.  Interaction of VP16-213 with the DNA repair antagonist chloroquine.

Authors:  A M Arnold; J M Whitehouse
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

4.  Autophagy inhibition for chemosensitization and radiosensitization in cancer: do the preclinical data support this therapeutic strategy?

Authors:  Molly L Bristol; Sean M Emery; Paola Maycotte; Andrew Thorburn; Shweta Chakradeo; David A Gewirtz
Journal:  J Pharmacol Exp Ther       Date:  2013-01-04       Impact factor: 4.030

5.  Enhancement by caffeine of sister-chromatid exchange frequency induced by antineoplastic agents in human lymphocytes.

Authors:  D C Mourelatos
Journal:  Experientia       Date:  1979-06-15

6.  Cyclophosphamide-resistant Yoshida ascites tumor cells and their cross resistance to some alkylating agents.

Authors:  H H Gerhartz; E Liss; H Schmidt
Journal:  J Cancer Res Clin Oncol       Date:  1979-07-27       Impact factor: 4.553

7.  Mice, men, mustard and methylated xanthines: the potential role of caffeine and related drugs in the sensitization of human tumours to alkylating agents.

Authors:  J E Byfield; J Murnane; J F Ward; P Calabro-Jones; M Lynch; F Kulhanian
Journal:  Br J Cancer       Date:  1981-05       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.